Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
10,212.8400
11,535.5770
8,270.1260
11,853.2660
10,693.1960
Cost of Revenue
4,042.0150
4,329.3300
3,841.6280
3,560.6240
4,060.0340
Gross Profit
6,170.8250
7,206.2470
4,428.4980
8,292.6420
6,633.1620
Operating Expense
7,279.6520
6,093.0680
4,622.0020
3,097.5970
2,726.2730
Operating Income
-1,108.8270
1,113.1790
-193.5040
5,195.0450
3,906.8890
Net Non Operating Interest Income Expense
-8,076.1170
-6,822.8160
-3,070.3250
-2,092.7840
-6,641.1320
Other Income Expense
-454.7410
-36.2400
72.1420
12.6530
-516.3950
Pretax Income
-9,639.6850
-5,745.8770
-3,191.6870
3,114.9140
-3,250.6380
Net Income Common Stockholders
-10,491.6090
-6,541.8950
-4,265.1680
2,248.3200
-5,813.6910
Diluted NI Available to Com Stockholders
-10,491.6090
-6,541.8950
-4,265.1680
2,248.3200
-5,813.6910
Basic EPS
-0.97
-0.95
-1.12
449.01
-4.12k
Diluted EPS
-0.97
-0.95
-1.12
431.67
-4.12k
Basic Average Shares
11,534.1320
6,928.3570
3,815.0670
4.8140
1.9400
Diluted Average Shares
13,105.0820
8,499.3070
3,815.0670
5
1.9400
Total Operating Income as Reported
-1,108.8270
1,100.5860
-193.5040
5,195.0450
3,906.8890
Total Expenses
11,321.6670
10,422.3980
8,463.6300
6,658.2210
6,786.3070
Net Income from Continuing & Discontinued Operation
-9,401.4000
-5,507.5920
-3,302.9990
3,028.3940
-5,429.5210
Normalized Income
-9,639.6850
-5,733.2840
-3,270.5210
3,023.7101
-4,647.9090
Interest Expense
8,076.1170
6,822.8160
3,070.3250
2,092.7840
6,641.1320
Net Interest Income
-8,076.1170
-6,822.8160
-3,070.3250
-2,092.7840
-6,641.1320
EBIT
-1,563.5680
1,076.9390
-121.3620
5,207.6980
3,390.4940
EBITDA
-1,561.1980
1,082.5910
-107.9010
5,228.4750
3,413.6260
Reconciled Cost of Revenue
4,042.0150
4,329.3300
3,841.6280
3,560.6240
4,060.0340
Reconciled Depreciation
2.3700
5.6520
13.4610
20.7770
23.1320
Net Income from Continuing Operation Net Minority Interest
-9,639.6850
-5,745.8770
-3,191.6870
3,114.9140
-3,250.6380
Total Unusual Items Excluding Goodwill
0
-12.5930
78.8340
115.4480
1,397.2710
Total Unusual Items
0
-12.5930
78.8340
115.4480
1,397.2710
Normalized EBITDA
-1,561.1980
1,095.1840
-186.7350
5,113.0270
2,016.3550
Tax Rate for Calcs
0
0
0
0.0002
0
Tax Effect of Unusual Items
0
0
0
24.2441
0
12/31/2022 - 12/22/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade